Louise Stone Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2022	Degrading SWI/SNF ATPases shows promise for treating prostate cancer.
1/2020	MAOA inhibitor phenelzine efficacious in recurrent prostate cancer.
1/2018	Prostate cancer: Castration resistance driven by a GI transcriptional circuit.
1/2018	Prostate cancer: Rapid testosterone cycling reverses castration resistance.
10/2017	Prostate cancer: A variety of therapy: ARVs mediate DDR.
10/2017	Prostate cancer: A weighty issue: changes in chromatin regulation.
1/2017	Prostate cancer: Peptidomimetics have potential.
1/2017	Prostate cancer: Mechanisms of cancer metabolism: mTORC1 mediates AMD1.
1/2017	Prostate cancer: On target - theranostic imaging for aggressive disease.
1/2017	Prostate cancer: Escaping enzalutamide: Malat1 contributes to resistance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Louise Stone Research Topics

Disease

29	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2014
7	Kidney Neoplasms (Kidney Cancer) 10/2016 - 08/2014
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2017
2	Neoplasms (Cancer) 01/2017 - 11/2014
1	Kidney Calculi (Kidney Stone) 01/2022
1	Wounds and Injuries (Trauma) 12/2020
1	Urolithiasis 06/2019
1	Genomic Instability 01/2018
1	Infections 01/2017
1	Neoplasm Metastasis (Metastasis) 02/2016
1	Communicable Diseases (Infectious Diseases) 06/2015
1	Fistula 06/2015
1	Urinary Retention 01/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2014

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2014
3	Sunitinib (Sutent)FDA Link 10/2016 - 01/2016
2	Testosterone (Sustanon)FDA Link 06/2019 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2016 - 08/2014
1	OxalatesIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Phenelzine (Nardil)FDA Link 01/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018
1	ChromatinIBA 10/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	enzalutamideIBA 01/2017
1	PeptidomimeticsIBA 01/2017
1	ChitosanIBA 01/2017
1	CholesterolIBA 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Docetaxel (Taxotere)FDA Link 10/2016
1	B7-H1 AntigenIBA 02/2016
1	Phosphotransferases (Kinase)IBA 02/2016
1	PlasticsIBA 01/2016
1	Exosome Multienzyme Ribonuclease ComplexIBA 01/2016
1	Sorafenib (BAY 43-9006)FDA Link 01/2016
1	ranatachykinin AIBA 09/2015
1	Messenger RNA (mRNA)IBA 08/2015
1	MicroRNAs (MicroRNA)IBA 08/2015
1	ProdrugsIBA 06/2015
1	Pharmaceutical PreparationsIBA 05/2015
1	alpha-2-HS-GlycoproteinIBA 04/2015
1	Papillomavirus Vaccines (HPV Vaccines)IBA 11/2014

Therapy/Procedure

5	Therapeutics 12/2020 - 01/2016
3	Castration 01/2018 - 01/2016
2	Prostatectomy (Retropubic Prostatectomy) 01/2016 - 10/2014
1	Precision Medicine 01/2017
1	Photochemotherapy (Photodynamic Therapy) 01/2017
1	Radiotherapy 01/2016
1	Length of Stay 06/2015
1	Catheters 01/2015